SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-260866"
 

Search: id:"swepub:oai:DiVA.org:uu-260866" > A novel trapping sy...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Rydevik, AxelUppsala universitet,Avdelningen för analytisk farmaceutisk kemi (author)

A novel trapping system for the detection of reactive drug metabolites using the fungus Cunninghamella elegans and high resolution mass spectrometry

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • 2014-09-10
  • Wiley,2015
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-260866
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-260866URI
  • https://doi.org/10.1002/dta.1714DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • A new model is presented that can be used to screen for bioactivation of drugs. The evaluation of toxicity is an important step in the development of new drugs. One way to detect possible toxic metabolites is to use trapping agents such as glutathione. Often human liver microsomes are used as a metabolic model in initial studies. However, there is a need for alternatives that are easy to handle, cheap, and can produce large amounts of metabolites. In the presented study, paracetamol, mefenamic acid, and diclofenac, all known to form reactive metabolites in humans, were incubated with the fungus Cunninghamella elegans and the metabolites formed were characterized with ultra high performance liquid chromatography coupled to a quadrupole time of flight mass spectrometer. Interestingly, glutathione conjugates formed by the fungus were observed for all three drugs and their retention times and MS/MS spectra matched those obtained in a comparative experiment with human liver microsomes. These findings clearly demonstrated that the fungus is a suitable trapping model for toxic biotransformation products. Cysteine conjugates of all three test drugs were also observed with high signal intensities in the fungal incubates, giving the model a further indicator of drug bioactivation. To our knowledge, this is the first demonstration of the use of a fungal model for the formation and trapping of reactive drug metabolites. The investigated model is cheap, easy to handle, it does not involve experimental animals and it can be scaled up to produce large amounts of metabolites. Copyright (c) 2014 John Wiley & Sons, Ltd.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hansson, AnnelieUppsala universitet,Avdelningen för analytisk farmaceutisk kemi(Swepub:uu)annha905 (author)
  • Hellqvist, AnnaUppsala universitet,Avdelningen för analytisk farmaceutisk kemi (author)
  • Bondesson, UlfUppsala universitet,Avdelningen för analytisk farmaceutisk kemi(Swepub:uu)ulfbonde (author)
  • Hedeland, MikaelUppsala universitet,Avdelningen för analytisk farmaceutisk kemi(Swepub:uu)mikahede (author)
  • Uppsala universitetAvdelningen för analytisk farmaceutisk kemi (creator_code:org_t)

Related titles

  • In:Drug Testing and Analysis: Wiley7:7, s. 626-6331942-76031942-7611

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Rydevik, Axel
Hansson, Annelie
Hellqvist, Anna
Bondesson, Ulf
Hedeland, Mikael
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Pharmaceutical S ...
Articles in the publication
Drug Testing and ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view